Analytical Data
-
Gene name
BTBD11
- Application
-
Alternative Names
BTBD11Ankyrin repeat and BTB/POZ domain-containing Protein BTBD11; BTB/POZ domain-containing Protein 11
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A6QL63
-
Expression Region
1-183aa
-
AA Sequence
MSDVTFLVEGRPFYAHKVLLFTASPRFKALLSSKPTNDGTCIEIGYVKYSIFQLVMQYLYYGGPESLLIKNNEIMELLSAAKFFQLEALQRHCEIICAKSINTDNCVDIYNHAKFLGVTELSAYCEGYFLKNMMVLIENEAFKQLLYDKNGEGTGQDVLQDLQRTLAIRIQSIHLSSSKGSVV
-
Molecular Weight
47.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BTBD11, a member of the BTB/POZ domain-containing protein family, has garnered significant attention in recent years due to its potential roles in various biological processes and diseases. This protein is implicated in the regulation of cellular pathways, particularly those involved in protein-protein interactions, transcriptional regulation, and cellular signaling. Research has suggested that BTBD11 may play a critical role in development and differentiation, as well as in the response to stress and inflammation. Its dysregulation has been linked to several pathological conditions, including cancers and autoimmune diseases. Given the growing interest in understanding the molecular mechanisms underlying these conditions, the study of BTBD11 is essential for unraveling its functional roles and therapeutic potential. Advances in recombinant protein technology have enabled researchers to produce BTBD11 in a laboratory setting, facilitating detailed investigations into its structure, function, and interactions with other cellular components. By elucidating the properties of BTBD11, researchers aim to uncover novel insights into its role in health and disease, paving the way for potential therapeutic interventions targeting this protein. Furthermore, understanding the molecular pathways involving BTBD11 may provide a basis for developing biomarker strategies for disease diagnosis or prognosis. Overall, the exploration of BTBD11's biology and pathology represents an exciting frontier in molecular and cellular biology, with significant implications for the treatment of various diseases.
